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Objectives. Our aim was to use noninvasive studies early after 
infarction to assess medium-term prognosis in patients with a 
first uncomplicated myocardial infarction. 
Background. Although the use of early postinfarction assess- 
ment to gauge short-term prognosis in myocardial infarction is 
well established, there have been few comprehensive evaluations 
of noninvasive methods for assessing medium- and long-term 
prognosis. 
Methods. We prospectively studied 115 consecutive patients 
<65 years old with a first acute uncomplicated myocardial 
infarction to evaluate the prognostic role of predischarge cardiac 
studies. These included submaximal exercise testing, thallium-201 
scintigraphy, radionuclide xercise ventriculography, two- 
dimensional echocardiography, ambulatory electrocardiographic 
(Holter) monitoring and cardiac catheterization. All patients 
without complications were followed up >5 years. 
Results. During the follow-up eriod, 78 patients (68%) devel- 
oped complications, which were severe in 37 (32%). Exercise 
thallium-201 scintigraphy ielded the highest percentage (77%) 
for correctly classified patients. It also had the highest predictive 
value for complications (97%) and severe complications (92%) 
when it was used in association with exercise testing and radio- 
nuclide ventriculography. The addition of cardiac atheterization 
did not improve on the predictive power of noninvasive studies. 
Four decision trees (exercise t sting + echocardiography, exercise 
testing + radionuclide ventriculography, thallium-201 +echocar- 
diography, thallium-201 + radionuclide ventriculography) al- 
lowed stratification of all patients in a high, intermediate or low 
risk category. The combination of thallium-201 scintigraphy and 
radionuclide ventriculography yielded the best results (90% pre- 
dictive value for complications if the outcome of both tests was 
positive), but there were no significant differences with the other 
models. 
Conclusions. Any combination of a test detecting residual 
ischemia or functional capacity, or both (exercise testing or 
thallium-201 scintigraphy), and a test assessing ventricular func- 
tion (echocardiography or radionuclide ventriculography) results 
in useful prognostic information in patients with an uncompli- 
cated first acute myocardial infarction. 
(JAm Coil Cardiol 1995;25:815-22) 
Residual myocardial ischemia, impairment of left ventricular 
systolic function and electrical instability are the major deter- 
minants of prognosis after myocardial infarction (1-3). In 
patients free from complications (Killip class III or IV, hypo- 
tension, ongoing myocardial ischemia, malignant arrhythmias 
or evidence of mechanical complications) during the acute 
phase and in those who do not appear to have a large infarct 
area, laboratory studies may give valuable prognostic nforma- 
tion. Such information may be obtained with noninvasive 
studies, such as exercise lectrocardiography (4-10), myocar- 
dial perfusion scintigraphy with thallium-201 (11-15), echocar- 
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diography (16-21), radionuclide ventriculography (22-26), 
ambulatory electrocardiographic (Holter) monitoring (27-31), 
and with coronary angiography and contrast ventriculography 
involving cardiac atheterization (32-36). The results of such tests 
are often redundant. Therefore, identification of the variables 
that best predict the functional status and prognosis i warranted. 
Although many studies (37-47) have evaluated the prog- 
nostic value of such tests after 1 year, either singly or in 
combination, and strategies for management have been de- 
rived from them (1,2,48-53), there has been no overall evalu- 
ation of all such tests with a longer follow-up period. We 
therefore performed a prospective 5-year follow-up study of 
patients <65 years of age with a first uncomplicated myocar- 
dial infarction, thus evaluating the long-term prognostic value 
of the diagnostic tests used during the acute phase of infarc- 
tion. 
Study patients. The present study group consisted of 115 
patients (109 men, 6 women) selected from 250 consecutive 
patients admitted to our coronary care unit with a first 
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myocardial infarction. The other 135 patients were excluded 
because they met one or more of the following criteria: age 
>65 years (n = 37), angina during admission (n = 28), death 
during admission (n = 28), symptomatic arterial disease of the 
lower limbs (n = 16), previous diagnosis of myocardial infarc- 
tion (n = 6), heart failure (Killip class III or IV) (n = 6), 
refusal to participate in the study (n = 6), severe associated 
heart disease (n = 6), poor life prognosis owing to severe 
associated isease (n = 6) and orthopedic nability to perform 
exercise testing (n = 2). 
The 115 patients in the study group were <65 years old 
(range 36 to 64, mean 52). They had no complications during 
the acute phase of infarction, no associated disease with a poor 
prognosis and no contraindications to cardiac catheterization 
or exercise testing. All gave written informed consent o 
participate in the study. 
The diagnosis of myocardial infarction was established by 
two of the following criteria: characteristic chest pain lasting 
>30 min, classic electrocardiographic (ECG) findings and 
creatine kinase (CK) and CK-MB isoenzyme l vels above twice 
the normal upper limit of our laboratory. 
A total of 84% of patients were smokers, 27% had had 
previous anginal attacks, 27% had hypertension a d 23% had 
diabetes mellitus. 
On the basis of ECG criteria, 51 of the 115 study patients 
had an inferior infarction, 56 an anterior infarction and 8 a 
non-Q wave infarction. Of the latter eight patients, seven had 
an inferior and one an anterior infarction by technetium-99m 
pyrophosphate scan. Thus, overall, 57 patients (49.6%) had an 
anterior and 58 (50.4%) had an inferior infarction. 
Twenty-five patients received thrombolytic therapy with 
streptokinase within 4 h after the onset of symptoms. There 
were no differences inclinical features, test results or follow-up 
data between patients with and without streptokinase therapy. 
At the time of exercise testing before hospital discharge, the 
patients were receiving the following medications: calcium 
channel blocking agents (n = 11), aspirin (n = 15), nitrates 
(n = 6), beta-adrenergic blocking agents (n = 2), digoxin (n = 
5), aprindine (n = 1), amiodarone (n = 1), and captopril (n = 
1). At 5-year follow-up, they were taking the following medi- 
cations: calcium channel blocking agents (n = 35), aspirin or 
other antiplatelet drugs (n = 27), beta-adrenergic blocking agents 
(n = 24), nitrates (n = 20), diuretics (n = 18), angiotensin- 
converting enzyme inhibitors (n = 9), digoxin (n = 8) and 
amiodarone (n = 3). 
Diagnostic Tests 
Before hospital discharge (7 to 15 days after admission), the 
following studies were performed in all patients: submaximal 
exercise testing, 201-thallium scintigraphy, radionuclide ven- 
triculography at rest and after exercise, two-dimensional echo- 
cardiography, 24-h Holter monitoring and cardiac atheteriza- 
tion including coronary angiography and left ventriculography. 
Exercise testing. The exercise test was performed on a 
bicycle ergometer with the patient in the sitting position. The 
initial work load was 50 W, with 25-W increments every 3 rains. 
The test was stopped when symptoms, hypotension or ST 
segment depression >0.3 mV developed or when 70% of the 
maximal predicted heart rate for the patient's age was achieved 
(220 beats/rain minus age in years). In 50% of cases, the test 
was subjectively maximal, as it was terminated on the patient's 
request because of symptoms or physical exhaustion. 
Thallium-201 scintigraphy. Between 30 and 60 s before the 
termination ofexercise, 2mCi of thallium-201 inchloride form 
was injected through a previously cannulated vein. Five min- 
utes after the end of exercise, imaging was started with a Picker 
scintillation camera, with parallel hole collimator and high 
sensitivity, interfaced to a PDP 11/34 digital computer, with a 
Gamma 11 application system. Imaging was performed imme- 
diately after exercise and 3 to 4 h later in three projections: 
anterior, 40 o left anterior oblique and 60 ° left anterior oblique 
(or left lateral in women). Image processing consisted of 
interpolated background subtraction, smoothing and 128 x 
128 interpolation, with application of a color scale propor- 
tional to activity. 
The left ventricle was divided into 5 segments in all 
projections (15 segments/patient), and each segment was as- 
signed a score of 0 to 3 depending on the activity (0 = absence 
of activity, 3 = maximal activity). All studies were evaluated by 
consensus of two experienced observers who also systemati- 
cally assessed pulmonary thallium-201 uptake. 
Radionuclide ventriculography. Between days 10 and 15 of 
the clinical course and within 48-h after thallium-201 scintig- 
raphy, multigated radionuclide ventriculography using in 
vivo-in vitro technetium-99m-labeled rythrocytes was per- 
formed. The information was collected in histogram format, 
using synchronization with the R wave on the ECG, and was 
stored in the computer as studies of 20 images/cardiac cycle 
and a minimal number of 200,000 counts/image or300 cycles. 
Overall left ventricular function was measured. Segmental 
ejection fraction was calculated by dividing the left ventricle 
into 12 radial segments. Parametric phase, amplitude image 
and phase histogram (Fourier analysis) were obtained, adjust- 
ing for the first harmonic (cosine function). 
Echocardiography. Between days 7 and 10 after admission, 
all patients underwent two-dimensional echocardiography with 
the use of an ATL Mark 300 device. Images were stored in a 
videocassette permitting normal, slow and frame to frame 
display. 
Overall left ventricular ejection fraction was calculated by 
the Chapman method (modified Simpson method), which 
permits calculation of end-diastolic and end-systolic volumes in 
the apical two- and four-chamber views. Calculations were 
obtained by two observers evaluating the mean of the two 
results. Left ventricular ejection fraction could be calculated by 
this method in 105 of the 115 patients. 
Regional wall motion was evaluated with a semiquantitative 
method in which the left ventricle was divided into 11 segments 
and a score assigned for wall motion (0 = normal, 1 = 
hypokinesia, 2 = akinesia, 3 = dyskinesia). Every segment was 
evaluated in more than one view and assigned the highest 
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obtained score. The final score was that agreed on by at least 
two of three observers. Complete wall motion analysis could be 
performed in 87 of the 115 patients. 
Hoiter monitoring. Arrhythmias were evaluated with an 
ICR (Instruments for Cardiac Research, Inc.) device (Holter 
Cardiography System 6201) that permits reading of a 1-h 
recording in 30 s. The frequency of events was recorded on an 
ICR Graphic Printer (model 6500). 
Cardiac catheterization. Left ventriculography and coro- 
nary angiography using the Seldinger technique were per- 
formed in all patients before hospital discharge. The degree of 
narrowing of the left main, left anterior descending, left 
circumflex and right coronary arteries and their major 
branches was subjectively evaluated. Coronary artery narrow- 
ing >50% in the left main coronary artery and >70% in the 
remaining vessels was considered significant. 
Follow.up. All patients were followed up in the outpatient 
clinic at 1, 3, 6 and 12 months and subsequently at yearly 
intervals until 5 years after hospital discharge. In every visit 
angina and dyspnea were clinically assessed, and functional 
class was assigned. Physical examination was directed toward 
identifying signs of heart failure. The attending physician 
recommended revascularization procedures for all patients 
who had disabling symptoms with the exception of one patient 
with left main disease. 
The following complications were identified after 5 years of 
follow-up: angina, new myocardial infarction, heart failure, 
coronary angioplasty, cardiac surgery and death. Patients were 
included in the complications group when any of these com- 
plications developed at any level of severity. 
Patients were included in the severe complications group on 
the basis of the following criteria: if severe angina (Canadian 
Cardiovascular Society functional classes III and IV) (54), 
severe heart failure (New York Heart Association functional 
classes III and IV) (55), reinfarction, angioplasty, cardiac 
surgery or death. 
Variables Selected for Analysis 
Dependent variables. Two dependent variables (complica- 
tions and severe complications) were selected for analysis. 
Independent variables. The following independent vari- 
ables were selected for the various tests. For exercise testing: 
maximal work load achieved, maximal systolic blood pressure 
during exercise, development of angina during the test, ST 
segment depression >0.1 mV 0.08 s after the J point and 
significant arrhythmias during the test or in the recovery phase. 
For thallium-201 scintigraphy: difference in score between late 
and early postexercise scans, overall number of ischemic 
segments, overall number of necrotic segments, presence of 
ischemia in nonnecrotic segments and pulmonary uptake of 
thallium-201. For two-dimensional echocardiography: left ven- 
tricular ejection fraction at rest, regional wall motion score and 
presence of left ventricular dyskinesia. For mdionuclide ven- 
triculography: left ventricular ejection fraction at rest and 
during exercise, rest and exercise jection fraction in all 12 
segments, rest dyskinesia, reduction of exercise jection frac- 
tion in segments not corresponding to necrotic areas and 
abnormalities in phase and amplitude during exercise in seg- 
ments not corresponding to necrotic areas, For Holter moni- 
toring: >10 premature beats/h and ventricular tachycardia of
>9 successive beats (56). This test was subsequently eliminated 
from analysis because the selected variables were not predic- 
tive of complications. For cardiac catheterization: two- or 
three-vessel narrowing >70% or left main coronary artery 
narrowing >50%, three-vessel narrowing >70% and dyskine- 
sia. 
To increase the statistical power, all of these variables were 
transformed into dichotomous variables, with a basal category 
of absence of risk [0] and a risk category [1]. Dichotomization 
of quantitative variables was performed on the basis of the 
mean values in each group (complications, no complications, 
severe complications) as threshold values. 
Length of follow-up. The follow-up period ranged from 
hospital discharge to the development of complications. In 
patients without complications, the follow-up interval was 5 
years. 
Statistical Analysis 
Bivariate analysis. The relation between the development 
of complications and severe complications was assessed with 
survival analysis. Survival curves were compared with use of 
the Tarone-Ware nonparametric linear rank test. 
Multivariate analysis. Two multiple Cox proportional haz- 
ards models were created for each diagnostic test, for compli- 
cations and severe complications, respectively, and including in 
both all the independent variables elected for the evaluated 
test. The MPLR (maximal partial ikelihood ratio) backward 
selection stepwise method was used for the analysis. 
From these models, the individual prediction of complica- 
tions [P(c)] and severe complications [P(sc)] at 5 years was 
calculated (57). As the resulting value is the estimated proba- 
bility of not having developed complications at 5 years, a cutoff 
point was established at 0.5, so that a patient with a value ->0.5 
was classified as without complications (negative test result) 
and one with a value <0.5 was classified as with complications 
(positive test result). 
Sensitivity, specificity and global value were also calculated 
for each test. The following equations were used: Sensitivity = 
Patients with positive test/Overall number of patients with 
complications. Specificity = Patients with negative test/Overall 
number of patients without complications. Global value = 
Correctly classified patients/All studied patients. 
Evaluation of the predictive capacity of the different diag- 
nostic tests. To assess which combination of tests had the 
highest predictive capacity, several fixed models of multiple 
logistic regression were created, using complications and se- 
vere complications as dependent variables, and the variables 
created in the preceding step as independent variables. 
To compare the different combinations a sessed, the posi- 
tive predictive value (Patients with complications/Patients with 
818 OLONA ET AL. JACC Vol. 25, No. 4 
FIRST MYOCARDIAL INFARCTION: 5-YEAR PROGNOSIS March 15, 1995:815-22 
positive test results) and the negative predictive value (Patients 
without complications/Patients with negative test results) for 
complications and severe complications were calculated by 
using the logistic regression prediction formula in the case that 
results of all the tests included in every combination were 
positive or negative, respectively. 
Decision trees. Decision trees (58) for each dependent 
variable (complications and severe complications) were cre- 
ated on the basis of the results of the preceding step. For both 
variables, several alternatives stem from the decision node. 
From each of these alternatives, depending on the positive or 
negative result of the tests included in them, three different 
predictive values indicating high, medium and low risk levels of 
complications orsevere complications were obtained. This risk 
categorization was used as a measure of effectiveness. 
The method used to calculate the multiple logistic regres- 
sion models was the maximal ikelihood ratio. The analysis of 
data was carried out with the statistical package BMDP (59). 
Resul ts  
Follow-up. Of the 115 patients included in the study, 78 
(68%) had 116 complications during the 5 follow-up years: 61 
experienced angina, 25 had heart failure, 13 required myocar- 
dial revascularization, 10 had reinfarction and 7 died. Compli- 
cations were considered severe in 37 patients (32%): class III 
or IV angina in 11, class III or IV in heart failure in 7, re- 
vascularization procedures in 13, reinfarction in 10 and death 
in 7. 
As early as 1 month after hospital discharge some compli- 
cations developed in 24% of patients and were severe in 11%. 
After 1 year of follow-up, 60% of patients had complications; 
subsequently, new complications developed in 2.5% of pa- 
tients/year. All severe complications appeared uring the 1st 3 
follow-up years (20% during year 1, 4% in year 2 and 8% in 
year 3); 43% of complications and severe complications devel- 
oped during the first month of follow-up. 
Patients with and without complications did not differ 
significantly with respect to age, gender, smoking habits, 
previous angina, diabetes, hypertension, enlarged heart on 
chest radiography, CK levels or site of infarction. 
Bivariate analysis. Table 1 shows the results of bivariate 
analysis for both complications and severe complications. 
Multivariate analysis. Tables 2 and 3 show the Cox pro- 
portional hazards models that permitted creation of the vari- 
ables defining, for each diagnostic test, the probability of 
complications and severe complications at 5 years. 
Table 4 shows the sensitivity, specificity and global value of 
the variables obtained in previous models after dichotomiza- 
tion using 0.5 as cutoff point. 
Table 5 shows the positive and negative predictive values of 
complications and severe complications for all the possible 
combinations of tests, assuming that the results were positive 
or negative. 
Decision trees. Decision trees were created for both com- 
plications and severe complications. From the decision node, 
four alternatives stemmed, including two diagnostic tests each: 
one test evaluating functional status or residual ischemia 
(exercise testing or thallium-201 scintigraphy) and the other 
test evaluating ventricular function (radionuclide ventriculog- 
raphy or two-dimensional echocardiography). Three predictive 
values were available for each alternative: those of two positive 
test results, one positive and one negative test result, and two 
negative test results. This procedure permitted classification of 
the patients into three risk categories: high, intermediate and 
low. The most effective alternative of the four analyzed deci- 
sion trees was the combination of thallium-201 scintigraphy 
and radionuclide ventriculography, although the results did not 
differ significantly from those of the other three (Fig. 1). 
Discuss ion  
Several previous tudies have used multivariate analysis to 
evaluate the prediction of postinfarction complications within 
the first follow-up year with conventional exercise testing 
(37-43), thallium-201 scintigraphy (44,45) and radionuclide 
ventriculography (45,46). However, attempts to compare the 
prognostic value of combinations ofthese investigations after 5 
years have been rare (42). 
Follow-up data. A remarkable feature of our 5-year fol- 
low-up series is the low mortality rate (6%) and the high 
incidence of complications (68%). Most of these developed 
early (43% of the combined group of total complications and 
severe complications were detected uring the first month of 
follow-up), thus emphasizing the need to identify high risk 
patients before hospital discharge. On the other hand, 
throughout the 5 follow-up years, 11 had angina grade III or 
IV, 7 had severe heart failure, 13 required revascularization 
procedures and 10 had reinfarction. 
Thallium-201 scintigraphy, either alone or in combination 
with other noninvasive tests, had the highest predictive value, 
the best combination being thallium-201 scintigraphy, exercise 
testing and radionuclide ventriculography (Tables 4 and 5); 
however, the combination of even the simplest ests (exercise 
testing and two-dimensional echocardiography) also had a 
good, although lower, predictive value. 
There were no significant differences among the four 
alternatives (exercise testing + echocardiography, exercise 
testing + radionuclide ventriculography, thallium-201 scintig- 
raphy + echocardiography, thallium-201 + radionuclide ven- 
triculography) in the proposed decision trees, although the 
best combination was thallium-201 scintigraphy and radionu- 
clide ventriculography. 
Comparison with other studies. Irrespective of the se- 
lected combination, the patients could be classified in one of 
the three risk categories (high, intermediate or low) by using a 
concise algorithm (Fig. 1). 
Some investigators (49,60) have recommended routine car- 
diac catheterization a d coronary arteriography in all patients 
after acute myocardial infarction (61). The Thrombolysis in 
Myocardial Infarction II (TIMI II) investigators studied the 
benefit of predischarge coronary arteriography in patients with 
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Tab le  1. Bivariate Analysis: Comparison of Survival Curves of Patients With No, Any or 
Severe Complications 
No Complications Complications Severe Complications 
No. No. p Value No. p Value 
Exercise testing 
Watts 0.05 0.12 
<-75 17 45 18 
>75 21 29 13 
Angina 0.08 0.01 
Yes 2 11 6 
No 36 66 25 
Arrhythmias 0.05 0.02 
Yes 2 16 6 
No 36 61 25 
Peak SBP 0.006 0.002 
<150 mm Hg 8 37 17 
>150 rnm Hg 30 37 13 
ST ~ 0.99 0.59 
>0.1 mV 16 32 14 
<-0.1 mV 22 43 17 
Thallium-201 scintigraphy 
Necrotic segments 0.05 0.05 
>5 13 39 17 
-<5 25 35 13 
lschemic segments 0.005 0.001 
>1 9 46 21 
<- 1 29 29 10 
Dist. ischemia 0.09 0.03 
Yes 6 32 14 
No 32 43 17 
Pulmonary' thallium-201 uptake 0.37 0.13 
Yes 4 13 7 
No 34 62 24 
Radionuclide ventriculography 
Rest EF 0.0005 0.01 
->40 27 33 15 
<40 11 44 16 
Ex EF 0.001 0.01 
->40 30 46 19 
<40 8 31 12 
Ex EF - Rest EF 0.24 0.65 
Negative 10 22 8 
Positive 28 55 23 
Fourier 0.07 0.10 
Abnormal 19 38 14 
Normal 19 39 17 
Dyskinesia 0.90 0.85 
Yes 4 20 7 
No 34 57 24 
Two-dimensional echocardiography 
Score 0.0t 0.004 
>8 6 29 12 
<8 25 34 9 
EF 0.004 0.004 
->45% 7 32 11 
<45% 24 31 10 
Dyskinesia 0.03 0.01 
Yes 4 21 8 
No 27 41 12 
Cardiac catheterization 
Vessels with >70% narrowing 0.22 0.001 
3 4 12 22 
<3 34 65 9 
Dyskinesia 0.02 0.24 
Yes 9 28 11 
No 29 49 20 
Dist. = present in segments not involved by necrosis; EF - ejection fraction: Ex - exercise; Fourier = abnormalities 
in amplitude and phase during exercise in segments not corresponding to the necrotic area; SBP = maximal systolic blood 
pressure; ST ~, - ST segment deprcssion. 
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Tab le  2. Cox Proportional Hazards Model for Complications: 
Variables With Statistical Significance 
Coefficient SE RR 95% CI 
Exercise testing 
Peak SBP <150 mm Hg 0.86 0.3 2.3 1.3-4.2 
Angina 0.79 I).4 2.2 1.01-4.8 
Thafiium-20t scintigraphy 
Necrotic segments >5 0.64 0.32 1.9 1.02-3.5 
Ischemic segments >1 1.17 0.38 3.2 2.2-6.7 
Radionuclide v ntriculography 
Rest EF <40% 0.83 0.4 2.3 1.13-4.6 
Two-dimensional echocardiography 
Score >8 1.03 0.4 2.4 1.8-6.8 
Dyskinesia 0.86 0.4 2.8 0.98-5.7 
Cardiac atheterization 
Dyskinesia 0.5 0.25 1.7 1.01-2.7 
CI = confidence interval; EF = ejection fraction; RR - rate ratio; SE 
standard error; other abbreviations as in Table 1. 
Table 4. Sensitivity, Specificity and Global Value of the Study Tests 
for Probability of Complications and Severe Complications* 
Global 
Sensitivity Specificity Value 
Complications 
Exercise testing 57% (71) 74% (38) 63% 
Thallium-201 scintigraphy 91% 171) 50% (38) 77% 
Radionuclide ventriculography 57% (71) 71% (38) 62% 
Two-dimensional echocardiography 60% (56) 62% (31) 60% 
Cardiac atheterization 36% (71) 76% (38) 50% 
Severe complications 
Exercise testing 60% (29) 58% (38) 59% 
Thallium-201 sciotigraphy 65% (29) 76% (38) 71% 
Radionuclidc ventriculography 55% (29) 70% (38) 66% 
Two-dimensional echocardiography 55% (18) 80% (31) 71% 
Cardiac atheterization 64% (29) 63% (38) 64% 
*The cutoff point was 0.5. The numbers in parentheses indicate the number 
of patients in the denominator. See text for definitions of sensitiviW, specificity 
and global value. 
acute myocardial infarction given thrombolytic therapy. They 
compared the outcome of patients assigned to routine coro- 
nary arteriography with that of patients assigned to conserva- 
tive management who underwent coronary arteriography only 
if myocardial ischemia recurred spontaneously or at predis- 
charge exercise testing. There was no difference in the rate of 
death, nonfatal reinfarction or myocardial revascularization 
procedures between the two groups. 
In our series cardiac catheterization did not enhance the 
predictive capacity of noninvasive studies. Therefore we do not 
think that routine coronary angiography is justified in these 
patients, both because it does not provide additional prognos- 
tic information and because it is invasive and more expensive 
than other studies. Catheterization would only have been 
performed in 60% to 75% of cases if it had been indicated in 
patients deemed to be at high risk on the basis of noninvasive 
studies. 
Our results are in agreement with data reported after 1 year 
Tab le  3. Cox Proportional Hazards Model for Severe 
Complications: Variables With Statistical Significance 
Coefficient SE RR 95% CI 
Exercise testing 
Peak SBP <150 mm Hg 0.88 0.3 2.4 1.8-4.4 
Angina 0.96 0.4 2.6 1.06-6.4 
Thallium-201 scintigraphy 
Necrotic segments >5 11.77 0.3 2.2 1.2-3.8 
Ischemic segments > 1 1.11 0.4 3 1.4-6.6 
Radionaclide ventriculography 
Rest EF <40% 1.3 0.3 3.7 2.05-6.5 
Two-dimensional echocardiography 
Score >8 1.16 0.4 2.7 1.5-7 
Dyskinesia 1.01 0.4 2.5 1.25-6 
Catheterization 
Vessels = 3 1.1 0.4 3 2.01-6.5 
Abbreviations a in Tables 1 and 2. 
of follow-up (47) in which the combination of thallium-201 
scintigraphy and radionuclide ventriculography had the best 
predictive value without remarkable differences among any 
decision algorithms. 
The reduction in the number of variables analyzed allowed 
us to obtain a higher statistical stability for assessing the 
prognosis of the different combinations of diagnostic tests 
using multivariate analysis. This is an important point, because 
the limitations of our study could result in lack of stability in 
the models created: The sample size is relatively small and the 
regression models cannot be validated. However, the biologic 
plausibility of our results and their agreement with data 
obtained in a l-year follow-up study support their validity 
Table 5. Predictive Value for Complications and Severe Complications 
for the Different Combinations of Diagnostic Tests 
Severe 
Complications Complications 
PV+ PV- PV+ PV- 
ET + TI-201 93% (28) 69% (28) 79% (16) 83% (24) 
ET + RNV 88% (34) 57%. (26) 74%(11) 92% (20) 
ET + ECHO 84%(37) 55%(38) 66%(19) 75%(39) 
TI-201 + RNV 90% (27) 60% (33) 87% (7) 91% (21) 
TI-201 + ECHO 90% (26) 65% (26) 80% (12) 72% (25) 
ECHO + RNV 89% (32) 60% (28) 70% (10) 78% (23) 
ET + TI-201 + RNV 97% (18) 75%(16) 92%(4) 87% (15) 
ET + T1-201 + ECHO 94% (19) 83% (22) 81%(10) 84% (19) 
ET + RNV* ECHO 87% (26) 64% (22) 78%(10) 87% (16) 
TI-201 + RNV + ECHO 96% (19) 72% (6) 93% (4) 94% (15) 
ET + T1-201 + RNV + ECHO 88% (20) 63% (19) 94% (4) 97% 112) 
Numbers in parentheses indicate the number of patients in each grouping. 
ECHO echocardiography; ET = exercise testing; PV+ (PV-) = positive 
(negative) predictive value; RNV - radionuclide ventriculography; T1-201 = 
thallium-201 scintigraphy. 
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TI-201+RNV + 
TI-201+ECHO + 
ET + RNV + 
ET + ECHO + 
90% (27) 
High risk 
68% (49) Intermediate risk 
35% (33) Low risk 
90% (26) High risk 
70% (36) Intermediate risk 
37% (26) Low risk 
86% (37) High risk 
65% (34) 
Intermediate risk 
35% (38) Low risk 
84% (34) High risk 
66% (28) Intermediate risk 
44% (26) LOW risk 
87% (12) 
, High risk 
(3o) Intermediate risk 
(25) LOW risk 
8o% (7) High risk 
48% (21) 
Intermediate risk 





ET+ RNV (~ 37% (19) 
Y 8% (29) 
66% (11) 
ET + ECHO (~ 44% (18) 
Y 25% (2o) Low risk 
Figure 1. Decision trees for the combination of the four noninvasive 
studies showing the probability of complications (top) and severe 
complications (bottom), depending on the results of the two studies in 
each branch. Positive results in both = high risk; positive results in 
one - intermediate risk; negative results in both = low risk. Numbers 
in parentheses indicate number of patients. ECHO = echocardiography; 







although a different procedure was used to select variables for 
analysis. 
Conclusions. We conclude from our data that in patients 
<65 years old with a first uncomplicated myocardial infarction, 
the performance before hospital discharge of a study evaluat- 
ing functional status and residual ischemia (exercise testing or 
thallium-201 scintigraphy) and one assessing left ventricular 
function (echocardiography or radionuclide ventriculography) 
permits assessment ofthe long-term risk of complications. The 
simultaneous performance ofcardiac atheterization does not 
enhance the prognostic value of noninvasive t sts. 
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